Composition & Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

27 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-03-31

Study Completion Date

2024-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators previous research has suggested that lipid (fatty) composition in the muscle cells of mice plays a key role in their insulin sensitivity. The purpose of this study is to determine whether these specific fat signatures translate to humans by comparing the muscle of healthy patients to those with pre-diabetes, or "the metabolic syndrome".

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Investigating Muscle Failure in Diabetic Myopathy

NCT05685927

Diabetes Mellitus Obesity Chronic Hyperglycaemia +3 more

ACTIVE_NOT_RECRUITING

PGC-1 and Mitochondrial Dysfunction in Diabetes

NCT01724515

Diabetes Obese

COMPLETED NA

Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy

NCT02635269

Metabolism, Inborn Errors Lipid Metabolism, Inborn Errors Carbohydrate Metabolism, Inborn Errors +20 more

UNKNOWN NA

Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin Resistance

NCT01240252

Type 2 Diabetes Mellitus

COMPLETED PHASE1

Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity

NCT00523562

Metabolic Syndrome X Liver Diseases

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Comp-SR study explores the role of lipid metabolism in key metabolic pathways in skeletal muscle. It is a translation of previous research done in mice studying the effects and functions of certain key enzymes involved in lipid metabolism found to be associated with insulin resistance. These enzymes are fatty acid synthase (FAS), choline/ethanolamine phosphotransferase 1 (CEPT1) and sarcoplasmic-endoplasmic reticulum ATPase (SERCA). Based on the investigators research, it appears that the activity and function of these enzymes determines the ratio of certain phospholipids in the sarcoplasmic reticulum (SR), namely phosphatidylethanolamine (PE) and phosphatidylcholine (PC). Furthermore, the investigators have found that the ratio of these phospholipids correlates with the mouse's sensitivity to insulin.

Based on the muscle biopsies of four healthy persons, it was found that human muscle contains similar phospholipids and phospholipid ratios to mice. It is hypothesized that these phospholipid signatures may be predictive of the metabolic status of humans as well. The specific aims of this study are to determine if the composition and function of the sarcoplasmic reticulum is altered in persons with the metabolic syndrome compared to lean controls. This knowledge could provide new understanding of impediments to effective therapy, novel biomarkers of disease progression, and innovative treatment targets for diabetes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Metabolic Syndrome

Muscle biopsy to determine sarcoplasmic reticulum composition and function, Oral Glucose tolerance test with insulin levels at time points to determine Insulin sensitivity, DEXA scan to determine lean muscle and fat mass

muscle biopsy

Intervention Type PROCEDURE

A member of the study team will obtain a small sample of muscle tissue from the patient's thigh (vastus lateralis muscle).

Control

Muscle biopsy to determine sarcoplasmic reticulum composition and function, Oral Glucose tolerance test with insulin levels at time points to determine Insulin sensitivity, DEXA scan to determine lean muscle and fat mass

muscle biopsy

Intervention Type PROCEDURE

A member of the study team will obtain a small sample of muscle tissue from the patient's thigh (vastus lateralis muscle).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

muscle biopsy

A member of the study team will obtain a small sample of muscle tissue from the patient's thigh (vastus lateralis muscle).

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Sedentary: No routine exercise, walking \<10,000 steps per day Age \>18 and \<65 Body Mass Index (BMI) \<32 Healthy by physical exam (patient is devoid of major acute or chronic illness) No significant abnormality in screening labs

Exclusion:

Currently on any significant prescription medications other than oral contraceptives in women Currently Pregnant Current Tobacco Use

Subjects with the Metabolic Syndrome

Inclusion:

Sedentary: No routine exercise, walking \<10,000 steps per day Age \>18 and \<65 Body Mass Index (BMI) \>30

Meet at least three of the following Adult Treatment Panel (ATP) III criteria for the metabolic syndrome:

waist circumference \> or = 40 inches in men, \> or = 35 inches in women blood triglycerides \> or = 150 mg/dL blood HDL cholesterol \<40 mg/dL in men, \<50 in women blood pressure \> or = 130 mmHg systolic, or \> or = 85 mmHg diastolic fasting blood sugar \> or = 100 mg/dL

Exclusion:

Diagnosed with Type 2 diabetes, coronary artery disease, cancer, liver, lung, or kidney disease or any other major illness

Currently on any significant prescription medications other than:

oral contraceptives in women More than two standard medication for stage 1 hypertension in men or women (blood pressure 140-159/90-99) Currently Pregnant Current Tobacco Use

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes